GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 58 filers reported holding GEMINI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $123,000 | +53.8% | 75,000 | +57.9% | 0.00% | +50.0% |
| Q2 2022 | $80,000 | -50.9% | 47,500 | -59.6% | 0.00% | -33.3% |
| Q1 2022 | $163,000 | -52.3% | 117,500 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $342,000 | -48.7% | 117,500 | -28.8% | 0.01% | -53.8% |
| Q3 2021 | $667,000 | – | 165,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $4,115,000 | 10.37% |
| Foresite Capital Management V, LLC | 2,435,125 | $4,115,000 | 2.88% |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $8,880,000 | 1.48% |
| Orbimed Advisors | 5,826,224 | $9,846,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,372,267 | $4,009,000 | 0.15% |
| Boxer Capital, LLC | 1,300,000 | $2,197,000 | 0.14% |
| Ikarian Capital, LLC | 443,096 | $749,000 | 0.14% |
| K2 PRINCIPAL FUND, L.P. | 292,745 | $495,000 | 0.06% |
| HARVARD MANAGEMENT CO INC | 250,000 | $423,000 | 0.05% |
| Marquette Asset Management, LLC | 87,648 | $148,000 | 0.04% |